Ameet Sarpatwari

33PUBLICATIONS
50CO-AUTHORS
Toxicology (incl. clinical toxicology)Behavioural epidemiologyCardiology (incl. cardiovascular diseases)Pharmacology and pharmaceutical sciences not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Sep 03, 2026
Communicating Drug Safety and Safe Use Conditions in Risk Evaluation and Mitigation Strategy Materials.

|Aug 13, 2026
Factors influencing FDA drug approval decisions beyond clinical trial evidence: a scoping review.

|Jul 10, 2026
Prevalence and frequency of haematological testing in patients initiating clozapine in the USA.

|May 15, 2026
Post-Approval Pediatric Use of Drugs Granted Waivers from Pediatric Testing.

|Feb 06, 2026
Risk of neutropenia-related hospitalisation among clozapine initiators.

Ameet Sarpatwari, Mufaddal Mahesri, Joyce Lii

|Oct 11, 2025
Patient Perceptions of and Experiences with Risk Evaluation and Mitigation Strategies.

Ameet Sarpatwari, Su Been Lee, Heidi Zakoul

Pageof 6

Frequent Collaborators

10 joint publications

Aaron S Kesselheim

3 joint publications

Benjamin N Rome

3 joint publications

Gerald J Dal Pan

3 joint publications

Gita A Toyserkani